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ABSTRACT
Objectives: The study was undertaken to correlate the blood groups and clinical presentations in malaria patients
and to understand the differential host susceptibility in malaria.
Methods: From October 2007 to September 2008, malaria positive patients’ samples were evaluated in this
study. Hemoglobin, total leukocyte count, and platelet  count of each patient were done on an automated cell
counter. After determining the blood groups, malarial species and the severity of clinical course were correlated.
Results: A total of 100 patients were included in the study, of which 63 cases were positive for Plasmodium
falciparum and 37 cases were positive for P. vivax infection and 11 patients had mixed infection. The results of
the blood groups showed 22 – ‘A’ group, 42 – ‘B’ group, 35 – ‘O’ group and 1 was ‘AB’ group. When the clinical
courses between different groups were compared using the following parameters for severe infection—a parasitic
load of >10/1000 RBCs, severe anemia with hemoglobin < 6 g%, platelet count of <10,000/mm3, hepato or
splenomegaly or clinical signs of severe malaria such as fever >101oF and other organ involvement, it was
observed that ‘O’ group had an advantage over other the groups. The difference in rosetting ability between red
blood cells of different ‘ABO’ blood groups with a diminished rosetting potential in blood group ‘O’ red blood
cells was due to the differential host susceptibility.
Conclusion: ‘O’ group had an advantage over the other three blood groups. Based on literature and the results of
this study, the diminished rosetting potential in blood group ‘O’ red blood cells is suggested as the basis for the
differential host susceptibility.
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INTRODUCTION
The association of genetic markers with malaria has
been the subject of numerous investigations, since the pro-
tection afforded by sickle-cell hemoglobin against infec-
tion by falciparum malaria parasite. A broad range of avail-
able evidence suggests that the origin, distribution and
relative proportion of ABO blood groups in humans may
have been directly influenced by selective genetic pres-
sure from Plasmodium falciparum infection1. Clinical
reports of ABO blood groups and P. falciparum infec-
tion, reveals a correlation between disease severity and
ABO groups. However, several studies undertaken have
been unable to link ABO blood groups to the incidence of
malaria or to the repeat attacks of malaria2,3.
Recent studies of the pathogenesis of malaria have
shown that parasite triggered red blood cell rosette forma-
tion is associated with the severity of clinical disease and
malaria4,5. Rosetting was established as a P. falciparum
virulence factor, the expression of which is modified by a
variety of host factors. Anti-rosetting activity, presum-
ably mediated by antibodies, was found in sera from pa-
tients in malaria endemic areas, and it was demonstrated
that such activity was more abundant in individuals with
uncomplicated malaria than in those with cerebral disease,
suggesting that humoral immunity protects against rosette
formation in vivo. Erythrocytes from individuals with
sickle-cell trait, -and -thalassemia trait or with HbE
formed smaller and weaker rosettes than did normal HbAA
red blood cells. Recently, even P. vivax infection has been
reported with clinical severity. There is a paucity of hos-
pital-based, comparative studies to investigate the rela-
tionship between blood group types and severity of ma-
larial infections. This study was undertaken to fill up the
lacunae in understanding the relationship between blood
group phenotypes and malaria in a hospital environment.
The objectives of the present study were: (i) to screen and
estimate the incidence of malaria in a hospital environ-
ment; and (ii) to correlate the blood groups and the clini-
cal presentations including outcome in malaria patients. J Vector Borne Dis 48, March 2011 8
MATERIAL & METHODS
This study was conducted during period from Octo-
ber 2007 to September 2008 on blood samples from pa-
tients presented with malaria and confirmed as positive in
St. John’s Medical College Hospital. The diagnosis was
based on peripheral smear and quantitative buffy coat
method (QBC). Blood group was determined by forward
and reverse method. Hematological parameters which in-
cluded hemoglobin, total leukocyte count and platelet count
of each patient were done on automated cell counter. The
demographic details of the patients and clinical details were
obtained from case records of the patients. Malarial spe-
cies and the severity of clinical course were correlated with
blood groups.
The clinical course between the different groups was
compared using the following parameters for severe in-
fection:
 a parasitic load of >10/1000 RBCs
 severe anemia with hemoglobin <6 g%
 platelet count of <10,000/mm3
 hepato or splenomegaly or
 clinical signs of severe malaria such as fever >101o F
and
 other organ involvement
RESULTS
 Among 11,552 smears screened during this period,
100 patients turned out to be positive and all the 100 samples
were evaluated by both QBC method and thick and thin
Leishman stained smears. The species of malarial para-
sites were P. falciparum (Pf) (63%); P. vivax (Pv) (37%)
and 11 patients had mixed infection of both Pv and Pf.
Among 100 patients, 22 were ‘A’ positive, 42 ‘B’ posi-
tive, 35 ‘O’ positive and 1 ‘AB’ positive. Irrespective of
the blood group, the number of patients affected by P.
falciparum was  more than P. vivax. The only patient who
had AB positive group had P. falciparum and was hospi-
talized as Intensive Care Unit patient. Among the patients
who had mixed infection, 6 had ‘A’ group, 3 ‘B’ group
and 2 ‘O’ group.
Malaria affected all age groups and the age ranged
from 1 to 71 yr old (M : F 8 : 2). The number of adults
affected was more (n = 82) than the children (n = 18).
Among the adults, the prevalence was more in the younger
age group. Among 18 in the pediatric age group, 6 were
treated in ICU, while the rest were treated as inpatients.
One year old child, though affected by Pv, was in ICU as
the hemoglobin was low (4.9 g%).
Although the majority of them were inpatients (98%)
and only 2 were managed as outpatients, both of them
were affected by P. falciparum. Among 98% hospitalized
patients, 37% were affected by P. vivax and 61% by P.
falciparum. When the clinical severity was compared with
blood groups, it was observed that ‘O’ group had an ad-
vantage (Fig. 1). The laboratory investigations are sum-
marized in Table 1.
DISCUSSION
Malaria has been known since antiquity. Much new
information has emerged since a relationship between ABO
and malaria was first suggested >40 years ago6. How-
ever, the correlation of severity of malarial infection to
the patient’s blood group has been of recent interest in the
quest for the answers to the factors influencing clinical
course of the disease. The observation by Miller et al7
that human erythrocytes lacking the  Duffy blood group
antigens are refractory to invasion by P. vivax parasites
indicate the usefulness of studying  the association of blood
group with malaria. In the Indian scenario, the literature
relating to malaria and the blood groups are sparse and
have mixed results. Thakur and Verma8 in their study,
concluded that ABO blood groups do not show differen-
Table 1. Summary of the salient laboratory features and blood group phenotype
Details Parasite species ‘A’ ‘B’ ‘O’
Number  affected Pf 14 27 21
Pv 81 5 1 4
Adult Pf 12 23 14
Pv 81 3 7
Hb range (g%) Pf 5.2–15.2 6.7–13.9 6.5–14.6
Pv 7.6–13.5 8.9–14.1 7.4–14.4
Total WBC count (per mm3) Pf 2300–24,000 2900–28,700 3500–11,400
Pv 3200–9800 3200–6400 2800–10,000
Platelet count (per mm3) Pf 10,000–1.4 lakh 9000–2.6 lakh 13,000–2.8 lakh
Pv 35,000–1.3 lakh 29,000–1.7 lakh 13,000–1.7 lakh 9 Deepa et al: ABO blood groups and malaria
tial susceptibility to malaria. Joshi et al9 reported no cor-
relation between ABO blood groups and malaria in Delhi.
Other studies indicated a possible relationship10. The
present study was attempted to correlate the blood groups
and the clinical presentations in malaria patients.
Among the adults, this study showed different age
groups had no significant correlation with incidence of
malaria. All age groups and both genders were affected.
However, the course of the disease in children was severe
than that among adults. In a cross-sectional study by Eli
et al11, influence of age and other factors that affect clini-
cal outcome of P. falciparum malaria in non-immune pa-
tients was evaluated. In their study of 135 patients with P.
falciparum malaria, 84 (62%) were <40 yr old, and only
5% developed severe malaria, compared with 18% who
were >40 yr old (odds ratio, 4.29); moreover, all deaths
occurred in the latter group. Male subjects did not differ
from female subjects with regard to severity of disease.
Similarly, in this study, the severity did not differ between
males and females. Red blood cells of children with se-
vere malaria-associated anemia (SMA) have acquired de-
ficiencies in the complement regulatory proteins comple-
ment receptor 1 (CR1, CD35) and decay accelerating factor
(DAF, CD55). Deficiencies in red blood cell CR1 and
CD55 in children with SMA were accompanied by a
marked decline in immune complex binding capacity and
increased C3b deposition in vivo and ex vivo. Importantly,
these changes were specific because they were not seen in
red blood cells of children with cerebral malaria or their
controls. These data suggest that the decline in red blood
cell CR1 and CD55 seen in children with SMA were of
physiologic significance and may predispose erythrocytes
to complement-mediated damage and phagocytosis in vivo.
All patients presented with fever and chills. The ini-
tial presentation of fever and chills was present irrespec-
tive of the blood groups. However, the number of ICU
admissions was more in ‘B’ group than other groups, and
also associated with P. falciparum infection. Among the
hospitalized adult patients, 4% had hemoglobin below 6
g/dl including both P. falciparum and P. vivax infections.
Though the predominant population was adults, in the
children who were affected, hemoglobin ranged from 4.9
to 13.8 g%. The reason for the anemia was because mac-
rophages not only clear infected erythrocytes but also ph-
agocytes destroyed uninfected red blood cells during ma-
laria infections. It has been observed in a prospective study
conducted in Orissa that the clinical features in Indian
children differed from those reported in most studies that
involved an African population. Multiple organ dysfunc-
tions emerged as an important presenting feature and a
new predictor of death in childhood malaria though ane-
mia causes morbidity12 with malaria. Anemia was also
seen with P. vivax infection. A one year old baby with P.
vivax had a hemoglobin value of 4.9 g% was treated in
ICU indicating other factors also played a role.
Leucocytosis was observed only in 5% of the patients,
though malaria is considered to be an infection. Areas that
cannot afford even simple laboratory diagnostic tests of-
ten use only a history of fever which is subjective as the
indication for malaria. Using Giemsa stained blood smears
Fig. 1: Comparison of O and non-O blood group with clinical
severity. By applying chi-square test, it was observed that
proportion of O group was 76% (26) compared to 24% (8)
in Non-O group which was significant (p<0.05), suggesting
that O group confers. When it was further calculated, the
severity was less in A than in B group.
Chi-square tests
df Asymp. sig Exact sig Exact sig
(2-sided) (2-sided) (1-sided)
Pearson chi-square 1 0.062
Continuity correlation 1 0.099
Likelihood ratio 1 0.057
Fisher’s Exact 0.080 0.048
Cross table
Severity of Blood group Total
malaria*   Non-O Gr       O Gr
Non-severe malaria 39 27 66
Severe malaria 26 8 34
Total 65 35 100
*Severe malaria is defined as: Hyperparasitaemia >10%
parasitaemia; severe anaemia with Hb <6 g%; clinical signs of
severe malaria with both hepatomegaly, splenomegaly or throm-
bocytopenia J Vector Borne Dis 48, March 2011 10
from children in Malawi, one study showed that unneces-
sary treatment for malaria was significantly decreased
when clinical predictors including temperature, pallor and
splenomegaly were used as treatment indicators13 (sensi-
tivity increased from 21 to 41%).
Platelet count was decreased in 80% of patients. In P.
falciparum infection platelet count dropped to <20,000/
mm3 irrespective of the blood group. When correlated with
parasitic load, it did not show any correlation. It has been
noted that the presence of thrombocytopenia in an endemic
area should alert malaria infection. Both non-immunologi-
cal destruction and immune mechanisms are implicated in
the pathogenesis of thrombocytopenia.
 Specific platelet-associated IgG antibodies that bind
directly to the malarial antigen in the platelets play a
role in the lysis of platelets.
 Elevated M-CSF levels in malaria, by increasing mac-
rophage activity may mediate platelet destruction.
 Oxidative stress damage-decreased platelet superox-
ide-dismutase and glutathione peroxidase activity and
high platelet lipid peroxidation.
Clinical severity, rather than incidence or prevalence
of detectable parasitemia, is a more relevant outcome to
assess ABO group and survival. Studies reporting clinical
features such as cerebral malaria carry more weight than
those reporting only laboratory markers such as percent
parasitemia, because the latter does not always predict
survival. Among those with a well-developed humoral
immunity, there is little correlation between high circulat-
ing parasitemia and severity of illness. Plasmodium
falciparum infection increases the serum levels of IgM
and IgG antibodies, and also IgE in individuals living in
endemic areas. The association of high anti PF IgE levels
with a reduced risk of developing clinical malaria sug-
gests the involvement of IgE in protection14.
In 1998, Fischer and Boone15 reported favourable out-
comes for group ‘O’ individuals compared with group ‘A’
among 489 patients in Zimbabwe with P. falciparum ma-
laria. They studied 209 outpatients and 280 severely ill
inpatients. Coma was 3-times more common among group
‘A’ individuals compared with non-A persons (9 of 104
group ‘A’ vs 11 of 385 with non-A blood, p = 0.008; odds
ratio, 3.6). Because patients with coma are at a higher
risk for death, this study supports the hypothesis that group
‘O’ individuals may have a survival advantage in severe
malaria. However, the sample size was insufficient to ob-
serve an effect of ‘ABO’ group on survival15.
Lell et al16 compared 100 cases of severe P. falciparum
malaria with 100 cases of mild malaria in Gabon. Severe
malaria was defined as either hyperparasitemia with
>0.25×1012 infected red blood cells (RBCs) per L or >10%
parasitemia; or severe anemia with Hb <5 g/L; or clinical
signs of severe malaria. Mild malaria cases had minimal
laboratory abnormalities and were treated as outpatients.
The ratio of group ‘A’ to group ‘O’ in patients with severe
malaria was 0.50, but was only 0.17 among those with
mild malaria (3-fold relative risk). Among all group ‘A’
individuals, 71% had severe malaria and only 29% mild
malaria (p<0.01). In contrast, among all group ‘O’ cases,
46% had severe malaria and 54% mild malaria (p<0.21).
In Sri Lanka, Pathirana et al5 assessed 243 adult cases
(mean age, 29.8 yr) of P. falciparum malaria (163 mild,
80 severe) compared with 65 control patients with other
infections5. The proportion of group ‘O’ in mild malaria
cases was 48%, but only 24% in severe malaria cases.
The distribution of ABO groups was significantly differ-
ent in severe malaria syndromes compared with uncom-
plicated malaria or the control population (p<0.001). Once
again, a case of severe malaria was nearly 3-times as likely
to be in group ‘A’ as O (p =0 .005). This study provided
the strongest statistical evidence of an association between
ABO and disease severity in P. falciparum infection.
Udomsangpetch et al17 showed a strong association
between rosette formation and ABO blood group, with
group ‘A’ and group ‘B’ RBCs (A > B) forming rosettes
more than group ‘O’ cells in each of 8 tested strains (p <
0.001). Rowe et al18 confirmed that among 154 isolates,
RBCs from group ‘O’ patients rosetted less (median ro-
sette frequency, 2%; range, 0–45%) than those from group
‘A’ (median, 7%; range, 0–82%; p <0 .01) or group ‘AB’
(median, 11%; range, 0–94%; p<0 .03). Chotivanich et
al19 found the highest relative rosette ratios in vitro among
RBCs from healthy donors who were group ‘A’ (2.7 ±
1.4) and ‘B’ (2.4 ± 1.1) compared with group ‘O’ (1.6 ±
0.7; p = 0.05). Most recently, Barragan et al20 confirmed
that group ‘A’ targets formed the strongest rosettes. In
addition, they reported that RBCs of group ‘A’ enzymati-
cally converted to RBCs, of group ‘O’ and Bombay RBCs
rosetted minimally and to the same degree. Thus, poten-
tiation of rosetting appears specific (but not exclusive) to
A and B antigens.
The adherence of parasitized RBCs to other cells is
central to the pathophysiology of severe malaria syndromes
including cerebral malaria, respiratory failure, multiorgan
failure, and death. Parasitized RBCs adhere to the vascu-
lature through a process termed “sequestration,” closely
mimicking inflammatory leukocyte attachment. Further-
more, half of infected RBC isolates form occlusive intra-
vascular aggregates, which consist not only of infected
RBCs bound to each other “autoagglutinates” but also 11 Deepa et al: ABO blood groups and malaria
infected RBCs bound to uninfected RBCs “homotypic RBC
rosettes” and/or to platelets “heterotypic RBC rosettes”.
Sequestration and rosette formation impair blood flow,
causing tissue ischemia and cell death. Not surprisingly,
in vitro rosetting is more pronounced in parasite strains
derived from patients with severe disease, particularly in
cases of cerebral malaria. In addition, host ABO group may
affect other aspects of malaria pathogenesis.
Malaria is known to have affected many erythrocyte
genes, including those concerned with globin synthesis,
membrane proteins, and RBC enzymes. Given the impor-
tance of RBCs in malaria, an influence on genes encoding
the most abundant antigens on the RBC membrane such
as blood groups is expected . It is also difficult to dissoci-
ate the role played by ABO sugars from the contribution
of other glycosylated adhesion molecules. The present study
including both P. falciparum and P. vivax infections pro-
vides supporting evidence in favour of an effect of ABO
group on disease severity as ‘O’ group provides advan-
tage over non ‘O’ groups.
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